Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Did you read the article about Pfizer’s CEO stat

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153908
(Total Views: 778)
Posted On: 12/05/2020 11:44:18 AM
Avatar
Posted By: lorbas
Re: FKAdamF. #67050
Quote:
Did you read the article about Pfizer’s CEO stating how he wasn’t certain if patients could transmit the virus after being vaccinated ? That was completely contrary to everything they had stated before , wasn’t it ?



The studies were mostly designed to test the hypothesis whether or not the vaccine protected people vaccinated from a symptomatic infection and to a certain extent from getting severe disease, not whether vaccinated people could transmit the virus to non-vaccinated people. (I think only AstraZeneca tested routinely, thus also has data on possible asymptomatic infections).

It is simply not known at this point and will take time to find out... Hence the importance to get 60%-70% vaccinated over the next years.

Nobody from Pfizer/Biontech or Moderna ever stated otherwise before to my knowledge, since the studies weren't designed to tell you that...

Quote:
But none has demonstrated that it prevents infection altogether, or reduces the spread of disease in a population. This leaves open the chance that those who are vaccinated could remain susceptible to asymptomatic infection — and could transmit that infection to others who remain vulnerable. “In the worst case scenario, you have people walking around feeling fine, but shedding virus everywhere,” says virologist Stephen Griffin of the University of Leeds, UK. Pfizer has said that its scientists are looking at ways to assess disease transmission in future studies. For now, AstraZeneca and the University of Oxford may be able to provide the first hints as to whether a vaccine can protect against such transmission. Although they have yet to publish complete results, their trial did test participants routinely for SARS-CoV-2, allowing investigators to pick up on asymptomatic infections. Early indications are that the vaccine may have reduced the frequency of such infections. That would suggest that disease transmission might also be reduced.



https://www.nature.com/articles/d41586-020-03441-8




(6)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us